← Back to Search

Device

Guided Physiologic Stenting for Coronary Artery Disease (DEFINE GPS Trial)

N/A
Waitlist Available
Led By Allen Jeremias, MD MSC FACC FSCAI
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing cardiac catheterization with planned PCI or possible ad hoc PCI
Following angiography, PCI is indicated in at least one coronary artery based on specific criteria
Must not have
Known severe aortic or mitral valve stenosis/insufficiency
Decompensated congestive heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days, 1 year and 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two methods for guiding a heart procedure called PCI. It targets patients who need this procedure. One method uses X-ray images, and the other uses pressure measurements to help doctors see where to work during the procedure.

Who is the study for?
This trial is for adults with stable or unstable angina, or NSTEMI who are undergoing cardiac catheterization and may need PCI. They should be willing to follow the study plan and give informed consent. Exclusions include severe heart failure, recent major heart procedures, pregnancy, other ongoing clinical studies, substance abuse issues, certain arrhythmias, and planned surgeries.
What is being tested?
The study compares two methods of guiding PCI in coronary artery disease: standard angiography versus intravascular pressure sensor guidance using Philips SyncVision system. It's a multi-center trial that randomly assigns participants to either method and can adjust its size based on interim results.
What are the potential side effects?
While specific side effects aren't listed here, typical risks of PCI include bleeding at the catheter insertion site, blood vessel damage during the procedure, allergic reactions to contrast dye used in angiography, irregular heartbeats (arrhythmias), and rarely heart attack.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a heart procedure to open blocked arteries.
Select...
I need a procedure to open blocked arteries in my heart.
Select...
I have angina or a type of heart attack known as NSTEMI.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a serious heart valve problem.
Select...
I have worsening symptoms of heart failure.
Select...
I have been diagnosed with cardiogenic shock.
Select...
I have irregular heartbeats that are unpredictable.
Select...
I have had an iFR pullback test on my heart's arteries.
Select...
I have a completely blocked artery.
Select...
I have a health condition that may shorten my life to under 2 years.
Select...
I have had a heart stent placed within the last year or plan to have one.
Select...
I have had a coronary artery bypass surgery in the past.
Select...
My kidney function is very low or I am on dialysis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days, 1 year and 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days, 1 year and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Angina-related Quality of Life
Cost effectiveness
Resource utilization

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: physiologically-guided armExperimental Treatment1 Intervention
Physiologically-guided PCI using the Philips SyncVision system for determining the PCI strategy
Group II: angiographically-guided armActive Control1 Intervention
Standard of care angiographically-guided PCI for determining the PCI strategy

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Coronary Artery Disease (CAD) include lifestyle modifications, medications, and revascularization procedures. iFR Co-Registration, a technique used during Percutaneous Coronary Intervention (PCI), measures pressure differences across coronary lesions without inducing hyperemia, allowing for precise stent placement. This method, along with other treatments like statins, antiplatelets, and beta-blockers, aims to reduce symptoms, prevent complications, and improve blood flow to the heart, ultimately enhancing patient outcomes.
Safety and efficacy of coronary laser ablation as an adjunctive therapy in percutaneous coronary intervention: a single-centre experience.Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials.

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
58 Previous Clinical Trials
14,124 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
371 Patients Enrolled for Coronary Artery Disease
Allen Jeremias, MD MSC FACC FSCAIPrincipal InvestigatorSaint Francis Hospital
Gregg W Stone, MDStudy ChairThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
15 Previous Clinical Trials
17,858 Total Patients Enrolled
10 Trials studying Coronary Artery Disease
13,145 Patients Enrolled for Coronary Artery Disease

Media Library

Philips SyncVision system with Philips pressure wires (Device) Clinical Trial Eligibility Overview. Trial Name: NCT04451044 — N/A
Coronary Artery Disease Research Study Groups: physiologically-guided arm, angiographically-guided arm
Coronary Artery Disease Clinical Trial 2023: Philips SyncVision system with Philips pressure wires Highlights & Side Effects. Trial Name: NCT04451044 — N/A
Philips SyncVision system with Philips pressure wires (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04451044 — N/A
~925 spots leftby Jun 2026